Mirae Asset Securities »

Sarepta Therapeutics shares owned by Mirae Asset Securities

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Mirae Asset Securities from 13F filings

Historical chart of Mirae Asset Securities investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Mirae Asset Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Mirae Asset Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.7M 23k 158.00

More positions owned by Mirae Asset Securities

Select Sector Spdr Tr Indl Indl (XLI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Ser Tr S&p Retail Etf (XRT)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Ishares Tr Ishares Semicdtr (SOXX)
Select Sector Spdr Tr Sbi Materials (XLV)
Spdr Ser Tr S&p Oilgas Exp (XOP)
Spdr Ser Tr S&p Biotech (XBI)
Select Sector Spdr Tr Sbi Int-utils Sbi Int-utils (XLU)
Spdr Ser Tr S&p Homebuild (XHB)
Apple (AAPL)
Spdr Ser Tr S&p Regl Bkg (KRE)

View all positions for Mirae Asset Securities

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
Capital Research and Management Company - Division 3
venBio Select Advisor
State Street Corporation
Henderson Group
Wellington Management Company
Morgan Stanley
Farallon Capital Management
Bank of New York Mellon
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Susquehanna International

View all funds holding Sarepta Therapeutics